Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K7XQ
|
||||
Former ID |
DNC004288
|
||||
Drug Name |
N-hydroxy-N-[1-(4-isobutylphenyl)ethyl]urea
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C13H20N2O2
|
||||
Canonical SMILES |
CC(C)CC1=CC=C(C=C1)C(C)N(C(=O)N)O
|
||||
InChI |
1S/C13H20N2O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)15(17)13(14)16/h4-7,9-10,17H,8H2,1-3H3,(H2,14,16)
|
||||
InChIKey |
FBLDKAJQWYMCKR-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Arachidonate 5-lipoxygenase | Target Info | Inhibitor | [1] | |
mRNA of human 5-lipoxygenase | Target Info | Inhibitor | [1] | ||
BioCyc Pathway | Aspirin-triggered lipoxin biosynthesis | ||||
Resolvin D biosynthesis | |||||
Leukotriene biosynthesis | |||||
Lipoxin biosynthesis | |||||
Aspirin triggered resolvin D biosynthesis | |||||
Aspirin triggered resolvin E biosynthesisPWY66-393:Aspirin-triggered lipoxin biosynthesis | |||||
Aspirin triggered resolvin E biosynthesis | |||||
KEGG Pathway | Arachidonic acid metabolism | ||||
Metabolic pathways | |||||
Serotonergic synapse | |||||
Ovarian steroidogenesis | |||||
Toxoplasmosishsa00590:Arachidonic acid metabolism | |||||
Toxoplasmosis | |||||
NetPath Pathway | IL4 Signaling PathwayNetPath_16:IL4 Signaling Pathway | ||||
PathWhiz Pathway | Arachidonic Acid MetabolismPW000044:Arachidonic Acid Metabolism | ||||
WikiPathways | Vitamin D Receptor Pathway | ||||
Arachidonic acid metabolism | |||||
Eicosanoid Synthesis | |||||
Selenium Micronutrient NetworkWP2650:Arachidonic acid metabolism | |||||
Selenium Micronutrient Network | |||||
References | |||||
REF 1 | J Med Chem. 1997 Feb 28;40(5):819-24.Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.